Cargando…

Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients

Detalles Bibliográficos
Autores principales:	Hoertel, Nicolas, Sánchez-Rico, Marina, Herrera-Morueco, Juan José, de la Muela, Pedro, Gulbins, Erich, Kornhuber, Johannes, Carpinteiro, Alexander, Becker, Katrin Anne, Cougoule, Céline, Limosin, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622106/ https://www.ncbi.nlm.nih.gov/pubmed/34837060 http://dx.doi.org/10.1038/s41380-021-01393-7

Ejemplares similares

Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, Nicolas, et al.
Publicado: (2022)

The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021)

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
por: Hoertel, Nicolas, et al.
Publicado: (2023)

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
por: Hoertel, N., et al.
Publicado: (2022)

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Virtual visits to inpatients by their loved ones during COVID-19
por: Rios, Izabel Cristina, et al.
Publicado: (2020)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, David, et al.
Publicado: (2022)

Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, D., et al.
Publicado: (2023)

P089 Coronavirus infection (COVID–19) in children with cystic fibrosis of the Russian Federation
por: Kondratyeva, E., et al.
Publicado: (2021)

Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
por: Becker, Katrin Anne, et al.
Publicado: (2021)

Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study
por: Sánchez-Rico, Marina, et al.
Publicado: (2021)

The ongoing impact of the Covid-19 pandemic on endometriosis patients: A survey of 1,089 UK patients
por: Spencer, J.I., et al.
Publicado: (2022)

COVID-19 is not influenza
por: Petersen, Eskild
Publicado: (2021)

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

Antipsychotic use and 28-day Mortality in Patients Hospitalized with COVID-19: a multicenter observational retrospective study
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Publicado: (2021)

Pontin/Tip49 acts as a novel regulator of JNK pathway
por: Wang, Xingjun, et al.
Publicado: (2018)

Viral arthritis and COVID-19
por: Parisi, Simone, et al.
Publicado: (2020)

The Lancet COVID-19 Commission
por: Sachs, Jeffrey D, et al.
Publicado: (2020)

Coagulation disorder in COVID-19
por: Kander, Thomas
Publicado: (2020)

COVID-19 and liver transplantation
por: Di Maira, Tommaso, et al.
Publicado: (2020)

COVID-19: the vasculature unleashed
por: Teuwen, Laure-Anne, et al.
Publicado: (2020)

Save the kidneys in COVID-19
por: Knight, Philip P., et al.
Publicado: (2020)

Digital technology and COVID-19
por: Ting, Daniel Shu Wei, et al.
Publicado: (2020)

COVID-19 and the cardiovascular system
por: Zheng, Ying-Ying, et al.
Publicado: (2020)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

COVID-19 and digital epidemiology
por: Kalteh, Ehsan allah, et al.
Publicado: (2020)

Azithromycin for severe COVID-19
por: Oldenburg, Catherine E, et al.
Publicado: (2020)

COVID-19 and the Swedish enigma
por: Claeson, Mariam, et al.
Publicado: (2021)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

Fatigue in the COVID-19 pandemic
por: Azzolino, Domenico, et al.
Publicado: (2022)

Triage in the time of COVID-19
por: Gilbert, Allison, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mob0h1h7gcvd6vk4a6jul3l1bb